{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:38:11Z","timestamp":1793299091579,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.beem.2024.101953","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T11:52:49Z","timestamp":1726919569000},"page":"101953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Update on clinical characteristics in the evaluation of phaeochromocytoma and paraganglioma"],"prefix":"10.1016","volume":"38","author":[{"given":"Annika M.A.","family":"Berends","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W.M.","family":"Lenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel N.","family":"Kerstens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2024.101953_bib1","series-title":"WHO classification of tumours: pathology and genetics of tumours of endocrine organ","author":"Loyd","year":"2017"},{"key":"10.1016\/j.beem.2024.101953_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12105-017-0786-1","article-title":"Update from the 4th edition of the World Health Organization classification of head and neck tumours: paragangliomas","volume":"11","author":"Williams","year":"2017","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.beem.2024.101953_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.beem.2024.101953_bib4","doi-asserted-by":"crossref","DOI":"10.1530\/JME-22-0167","article-title":"Genetic bases of pheochromocytoma and paraganglioma","volume":"70","author":"Casc\u00f3n","year":"2023","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.beem.2024.101953_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1353.001","article-title":"An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges","volume":"1073","author":"Manger","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.beem.2024.101953_bib6","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40200-016-0226-x","article-title":"Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms","volume":"15","author":"Soltani","year":"2015","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.beem.2024.101953_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2024.101953_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on endocrine hypertension of the European society of hypertension","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.beem.2024.101953_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ecl.2006.09.014","article-title":"Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma","volume":"35","author":"Brouwers","year":"2006","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2024.101953_bib11","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","article-title":"Cardiovascular manifestations of phaeochromocytoma","volume":"29","author":"Prejbisz","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.beem.2024.101953_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12020-019-02035-3","article-title":"Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome","volume":"65","author":"Hassan","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2024.101953_bib13","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac176","article-title":"Pheochromocytoma-induced Subarachnoid and Intracerebral Hemorrhage","volume":"7","author":"Agoubi","year":"2022","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.beem.2024.101953_bib14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S2213-8587(23)00256-5","article-title":"Catecholamine-induced hypertensive crises: current insights and management","volume":"11","author":"Nazari","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2024.101953_bib15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s002689900140","article-title":"Pheochromocytomas: tendency to degenerate and cause paroxysmal hypertension","volume":"20","author":"Ito","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2024.101953_bib16","first-page":"69","article-title":"Metabologenomics of phaeochromocytoma and paraganglioma: an integrated approach for personalised biochemical and genetic testing","volume":"38","author":"Eisenhofer","year":"2017","journal-title":"Clin Biochem Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2024.101953_bib17","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.6061\/clinics\/2012(Sup01)05","article-title":"Head and neck paragangliomas: clinical and molecular genetic classification","volume":"67","author":"Offergeld","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.beem.2024.101953_bib18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","author":"Eisenhofer","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.beem.2024.101953_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/ERC-21-0359","article-title":"Head\/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine","volume":"29","author":"Richter","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101953_bib20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/jc.2018-01707","article-title":"Pheochromocytoma characteristics and behavior differ depending on method of discovery","volume":"104","author":"Gruber","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib21","doi-asserted-by":"crossref","first-page":"e2251","DOI":"10.1210\/clinem\/dgaa965","article-title":"Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: a population-based study","volume":"106","author":"Ebbehoj","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib22","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1210\/clinem\/dgad401","article-title":"Pheochromocytomas most commonly present as adrenal incidentalomas: a large tertiary center experience","volume":"109","author":"Aggarwal","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-19-0159","article-title":"Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion","volume":"181","author":"Geroula","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2024.101953_bib24","first-page":"354","article-title":"Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series","volume":"56","author":"Sutton","year":"1981","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beem.2024.101953_bib25","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1210\/jc.2004-1398","article-title":"Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma","volume":"90","author":"Amar","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-17-0321","article-title":"Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center","volume":"7","author":"Falhammar","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2024.101953_bib27","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes","volume":"86","author":"Eisenhofer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib28","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2024.101953_bib29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2024.101953_bib30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/endrev\/bnae001","article-title":"Imaging of pheochromocytomas and paragangliomas","volume":"45","author":"Timmers","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2024.101953_bib31","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1210\/jc.2013-1844","article-title":"Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics","volume":"98","author":"Haissaguerre","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-023-01282-0","article-title":"Resistant hypertension: disease burden and emerging treatment options","author":"Flack","year":"2024","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.beem.2024.101953_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF02067379","article-title":"The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma","volume":"16","author":"Ito","year":"1992","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2024.101953_bib34","first-page":"869","article-title":"Screening for phaeochromocytoma: in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)","volume":"10","author":"Plouin","year":"1981","journal-title":"Nouv Presse Med"},{"key":"10.1016\/j.beem.2024.101953_bib35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2024.101953_bib36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2165\/00002018-200730110-00004","article-title":"Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management","volume":"30","author":"Eisenhofer","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.beem.2024.101953_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00004872-199403000-00008","article-title":"Spectral analysis of the systolic blood pressure signal in secondary hypertension: a method for the identification of phaeochromocytoma","volume":"12","author":"Meisel","year":"1994","journal-title":"J Hypertens"},{"key":"10.1016\/j.beem.2024.101953_bib38","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1097\/01.hjh.0000185714.60788.52","article-title":"Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients","volume":"23","author":"Zelinka","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.beem.2024.101953_bib39","first-page":"492","article-title":"Diurnal variation of blood pressure in patients with catecholamine-producing tumors","volume":"7","author":"Van Eps","year":"1994","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2024.101953_bib40","first-page":"S69","article-title":"Ambulatory blood pressure monitoring in secondary hypertension","volume":"9","author":"Padfield","year":"1991","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.beem.2024.101953_bib41","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-02644","article-title":"Blood pressure profile, catecholamine phenotype and target organ damage in pheochromocytoma\/paraganglioma","author":"Petrak","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/cs0580349","article-title":"Haemodynamics in patients with phaeochromocytoma","volume":"58","author":"Levenson","year":"1980","journal-title":"Clin Sci"},{"key":"10.1016\/j.beem.2024.101953_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.15.2_Suppl.I128","article-title":"A reevaluation of the hemodynamics of pheochromocytoma","volume":"15","author":"Bravo","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2024.101953_bib44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM197909273011302","article-title":"Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications","volume":"301","author":"Bravo","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2024.101953_bib45","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/cphy.c130034","article-title":"Pathophysiology and diagnosis of disorders of the adrenal medulla: focus on pheochromocytoma","volume":"4","author":"Lenders","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/j.beem.2024.101953_bib46","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/0895-7061(96)00057-X","article-title":"Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma","volume":"9","author":"Streeten","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2024.101953_bib47","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2024.101953_bib48","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/heartjnl-2013-304073","article-title":"Acute catecholamine cardiomyopathy in patients with pheaochromocytoma or functinal paraganglioma","volume":"99","author":"Giavarini","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.beem.2024.101953_bib49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/EJE-15-0483","article-title":"Life-threatening events in patients with pheochromcytoma","volume":"173","author":"Reister","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2024.101953_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/CRD.0000000000000141","article-title":"Cardiovascular manifestations of pheochromocytoma","volume":"25","author":"Gu","year":"2017","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.beem.2024.101953_bib51","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?","volume":"98","author":"Stolk","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cen.12324","article-title":"Phaeochromocytoma crisis","volume":"80","author":"Whitelaw","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2024.101953_bib53","unstructured":"Berends AMA. Pheochromocytoma and paraganglioma: changing vision 2023. University of Groningen. 10.33612\/diss.824280190."},{"key":"10.1016\/j.beem.2024.101953_bib54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2012-3020","article-title":"Pheochromocytoma crisis is not a surgical emergency","volume":"98","author":"Scholten","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2024.101953_bib55","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa441","article-title":"Approach to the patient: perioperative management of the patient with pheochromocytoma or sympathetic paraganglioma","volume":"105","author":"Berends","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2024.101953_bib56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/PL00013159","article-title":"Adrenal tumors and pregnancy","volume":"23","author":"Harrington","year":"1999","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.beem.2024.101953_bib57","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/1471-0528.14918","article-title":"Hormone-secreting adrenal tumours cause severe hypertension and high rates of poor pregnancy outcome; a UK Obstetric Surveillance System study with case control comparisons","volume":"125","author":"Quartermaine","year":"2018","journal-title":"BJOG"},{"issue":"10297","key":"10.1016\/j.beem.2024.101953_bib58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.beem.2024.101953_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S2213-8587(20)30363-6","article-title":"Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicenter retrospective cohort study and systematic review of literature","volume":"9","author":"Bancos","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2024.101953_bib60","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/1471-0528.16635","article-title":"Pregnancy and phaeochromocytoma\/paraganglioma: clinical clues affecting diagnosis and outcome - a systematic review","volume":"128","author":"Langton","year":"2021","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.beem.2024.101953_bib61","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ecl.2019.05.006","article-title":"Pheochromocytoma and pregnancy","volume":"48","author":"Lenders","year":"2019","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"2","key":"10.1016\/j.beem.2024.101953_bib62","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/bjs.8976","article-title":"Systematic review of phaeochromocytoma in pregnancy","volume":"100","author":"Biggar","year":"2013","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.beem.2024.101953_bib63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11886-021-01485-4","article-title":"Pheochromocytoma and paraganglioma in pregnancy: a new era","volume":"23","author":"Gruber","year":"2021","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.beem.2024.101953_bib64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S2213-8587(20)30371-5","article-title":"Phaeochromocytoma and pregnancy: looking towards better outcomes, less fear, and valuable recommendations","volume":"9","author":"Pacak","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2024.101953_bib65","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/EJE-16-0920","article-title":"Endocrinology in pregnancy: pheochromocytoma in pregnancy: case series and review of literature","volume":"177","author":"van der Weerd","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2024.101953_bib66","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1177\/106002809603001108","article-title":"Phenoxybenzamine placental transfer during the third trimester","volume":"30","author":"Santeiro","year":"1996","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.beem.2024.101953_bib67","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/00000542-200406000-00039","article-title":"Neonatal effects of long-term maternal phenoxybenzamine therapy","volume":"100","author":"Aplin","year":"2004","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.beem.2024.101953_bib68","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bcp.12981","article-title":"Doxazosin treatment of phaeochromocytoma during pregnancy: placental transfer and disposition in breast milk","volume":"82","author":"Versmissen","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.beem.2024.101953_bib69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/EJE-11-0528","article-title":"Pheochromocytoma and pregnancy: a deceptive connection","volume":"166","author":"Lenders","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2024.101953_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1753495X211006012","article-title":"Paraganglioma in pregnancy: a case series and literature review","volume":"15","author":"Eccles-Smith","year":"2022","journal-title":"Obstet Med"},{"key":"10.1016\/j.beem.2024.101953_bib71","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/a-0669-9556","article-title":"Catecholamine-induced cardiomyopathy in pheochromocytoma: how to manage a rare complication in a rare disease?","volume":"51","author":"Santos","year":"2019","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2024.101953_bib72","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S2213-8587(23)00256-5","article-title":"Catecholamine-induced hypertensive crises: current insights and management","volume":"11","author":"Nazari","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2024.101953_bib73","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/eurheartj\/ehy076","article-title":"International expert consensus document on Takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.beem.2024.101953_bib74","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.amjcard.2016.03.019","article-title":"Clinical features and outcome of pheochromocytoma-induced takotsubo syndrome: analysis of 80 published cases","volume":"117","author":"Y-Hassan","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.beem.2024.101953_bib75","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/HYPERTENSIONAHA.123.21902","article-title":"Cardiovascular complications in pheochromocytoma and paraganglioma: does phenotype matter?","volume":"81","author":"Petr\u00e1k","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2024.101953_bib76","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/cancers11081121","article-title":"Intricacies of the molecular machinery of catecholamine biosynthesis and secretion by chroman cells of the normal adrenal medulla and in pheochromocytoma and paraganglioma","volume":"11","author":"Berends","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2024.101953_bib77","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1210\/clinem\/dgaa488","article-title":"Ectopic ACTH- and\/or CRH-producing pheochromocytomas","volume":"106","author":"Elliott","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101953_bib78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2490-13-22","article-title":"Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature","volume":"13","author":"Beilan","year":"2013","journal-title":"BMC Urol"},{"key":"10.1016\/j.beem.2024.101953_bib79","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s00261-022-03443-2","article-title":"Bladder paragangliomas: a pictorial review","volume":"47","author":"Withey","year":"2022","journal-title":"Rev Abdom Radiol"},{"key":"10.1016\/j.beem.2024.101953_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/cen.15058","article-title":"Diagnosis and management of urinary bladder paragangliomas: a Sino-American-European retrospective observational study","author":"Pang","year":"2024","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2024.101953_bib81","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00345-021-03851-x","article-title":"Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review","volume":"40","author":"Li","year":"2022","journal-title":"World J Urol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T18:01:20Z","timestamp":1737309680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24001295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1521690X24001295"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101953","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on clinical characteristics in the evaluation of phaeochromocytoma and paraganglioma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101953"}}